Unni Syversen
Unni Syversen
Verifisert e-postadresse på ntnu.no - Startside
Sitert av
Sitert av
The effect of teriparatide [human parathyroid hormone (1–34)] therapy on bone density in men with osteoporosis
ES Orwoll, WH Scheele, S Paul, S Adami, U Syversen, A Diez‐Perez, ...
Journal of bone and mineral research 18 (1), 9-17, 2003
Adiponectin and its receptors are expressed in bone-forming cells
HS Berner, SP Lyngstadaas, A Spahr, M Monjo, L Thommesen, ...
Bone 35 (4), 842-849, 2004
Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: Impact on differentiation markers, apoptosis, and osteoclastic signaling
JO Gordeladze, CA Drevon, U Syversen, JE Reseland
Journal of cellular biochemistry 85 (4), 825-836, 2002
Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization
JE Reseland, U Syversen, I Bakke, G Qvigstad, LG Eide, Ø Hjertner, ...
Journal of Bone and Mineral Research 16 (8), 1426-1433, 2001
Two‐year results of once‐weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis
Alendronate Once‐Weekly Study Group, R Rizzoli
Journal of Bone and Mineral Research 17 (11), 1988-1996, 2002
Long-term serotonin administration induces heart valve disease in rats
BI Gustafsson, K Tømmerås, I Nordrum, JP Loennechen, A Brunsvik, ...
Circulation 111 (12), 1517-1522, 2005
Marked increase in gastric acid secretory capacity after omeprazole treatment.
HL Waldum, JS Arnestad, E Brenna, I Eide, U Syversen, AK Sandvik
Gut 39 (5), 649-653, 1996
Sustained nonvertebral fragility fracture risk reduction after discontinuation of teriparatide treatment
R Prince, A Sipos, A Hossain, U Syversen, S Ish‐Shalom, E Marcinowska, ...
Journal of Bone and Mineral Research 20 (9), 1507-1513, 2005
Expression and regulation of resistin in osteoblasts and osteoclasts indicate a role in bone metabolism
L Thommesen, AK Stunes, M Monjo, K Grøsvik, MV Tamburstuen, E Kjøbli, ...
Journal of cellular biochemistry 99 (3), 824-834, 2006
Serotonin and fluoxetine modulate bone cell function in vitro
BI Gustafsson, L Thommesen, AK Stunes, K Tommeras, I Westbroek, ...
Journal of cellular biochemistry 98 (1), 139-151, 2006
Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone
K Lovas, CG Gjesdal, M Christensen, AB Wolff, B Almas, J Svartberg, ...
European Journal of Endocrinology 160 (6), 993, 2009
The need for clinical guidance in the use of calcium and vitamin D in the management of osteoporosis: a consensus report
S Boonen, R Rizzoli, PJ Meunier, M Stone, G Nuki, U Syversen, ...
Osteoporosis international 15 (7), 511-519, 2004
Long-term effects of inhaled nicotine
HL Waldum, OG Nilsen, T Nilsen, H Rørvik, U Syversen, AK Sandvik, ...
Life sciences 58 (16), 1339-1346, 1996
Neuroendocrine differentiation in carcinomas of the prostate: do neuroendocrine serum markers reflect immunohistochemical findings?
A Angelsen, U Syversen, OA Haugen, M Stridsberg, OK Mjølnerød, ...
The Prostate 30 (1), 1-6, 1997
Neuroendocrine differentiation in human gastric carcinoma
HL Waldum, S Aase, I Kvetnoi, E Brenna, AK Sandvik, U Syversen, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 1998
Sub‐micron spongiform porosity is the major ultra‐structural alteration occurring in archaeological bone
G Turner‐Walker, CM Nielsen‐Marsh, U Syversen, H Kars, MJ Collins
International Journal of Osteoarchaeology 12 (6), 407-414, 2002
Quantifying histological changes in archaeological bones using BSE–SEM image analysis
G Turner–Walker, U Syversen
Archaeometry 44 (3), 461-468, 2002
Maximal strength training in postmenopausal women with osteoporosis or osteopenia
MP Mosti, N Kaehler, AK Stunes, J Hoff, U Syversen
The Journal of Strength & Conditioning Research 27 (10), 2879-2886, 2013
The proliferation markers Ki-67/MIB-1, phosphohistone H3, and survivin may contribute in the identification of aggressive ovarian carcinomas
G Aune, AK Stunes, S Tingulstad, Ø Salvesen, U Syversen, SH Torp
International journal of clinical and experimental pathology 4 (5), 444, 2011
Different skeletal effects of the peroxisome proliferator activated receptor (PPAR) α agonist fenofibrate and the PPARγ agonist pioglitazone
U Syversen, AK Stunes, BI Gustafsson, KJ Obrant, L Nordsletten, R Berge, ...
BMC endocrine disorders 9 (1), 1-13, 2009
Systemet kan ikke utføre handlingen. Prøv på nytt senere.
Artikler 1–20